Also called: Hodgkin Disease
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Hodgkin Lymphoma
Hodgkin lymphoma, also called Hodgkin disease, is a type of cancer that develops in the lymph system. Your lymph system is part of your immune system. It helps protect your body from infection and disease.
The lymph system is made up of tissues and organs that produce, store, and carry white blood cells. It includes your:
- Bone marrow
- Lymph nodes
- Lymphatic vessels
- Spleen
- Thymus
- Tonsils
Hodgkin lymphoma is one of the main types of lymphoma. The other is non-Hodgkin lymphoma. Each type starts in different types of white blood cells.
The cause of Hodgkin lymphoma is unknown. But there are certain people who are at higher risk of developing it.
Certain factors can make you more likely to develop Hodgkin lymphoma:
- Age. Hodgkin lymphoma is most common in early adulthood (age 20-39 years) and in late adulthood (age 65 years and older).
- Being male. The risk of adult Hodgkin lymphoma is slightly higher in males than in females.
- Past Epstein-Barr virus (EBV) infection. Having an infection with EBV as a young child or teenager increases your risk of Hodgkin lymphoma.
- A family history of Hodgkin lymphoma. Having a parent or sibling with Hodgkin lymphoma increases your risk of developing it.
The signs and symptoms of Hodgkin lymphoma may include:
- Painless, swollen lymph nodes in the neck, underarm, or groin
- Fever for no known reason
- Drenching night sweats (very heavy sweating during sleep)
- Weight loss for no known reason in the past 6 months
- Itchy skin, especially after bathing or drinking alcohol
- Fatigue
To find out if you have Hodgkin lymphoma, your provider:
- Will ask about your symptoms and medical history. This will include checking for signs of disease, such as lumps or anything else that seems unusual.
- May order some lab tests, such as: Complete blood count
- Blood chemistry studies
- Lactate dehydrogenase (LDH) test
- Erythrocyte sedimentation rate (ESR) test
- Blood tests to rule out other medical conditions
- May do imaging tests such as a CT and PET (positron emission tomography) scans
- May do a lymph node biopsy
Treatments for Hodgkin lymphoma include:
- Chemotherapy
- Radiation therapy
- Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells
- Cancer immunotherapy
Hodgkin lymphoma can usually be cured if it is found and treated early.
It sits within Cancers and Immune System.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Hodgkin Lymphoma
7,150 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaChildren's Oncology Group
- Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or VenetoclaxNational Heart, Lung, and Blood Institute (NHLBI)
- Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLAllogene Therapeutics
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)Merck Sharp & Dohme LLC
- Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell LymphomaNational Cancer Institute (NCI)
- Long-term Follow up Local Registry Study of Kymriah in South KoreaNovartis Pharmaceuticals
Research already completed
- Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin LymphomaCase Comprehensive Cancer Center
- Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantM.D. Anderson Cancer Center
- CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)M.D. Anderson Cancer Center
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- General Information about Adult Hodgkin LymphomaNational Cancer Institute
- Hodgkin LymphomaAmerican Cancer Society
- Hodgkin's LymphomaMayo Foundation for Medical Education and Research
Diagnosis and Tests
- Blood Count Tests: MedlinePlus Health TopicNational Library of Medicine
- Bone Marrow TestsNational Library of Medicine
- Needle BiopsyMayo Foundation for Medical Education and Research
- PDL1 (Immunotherapy) TestsNational Library of Medicine
- Stages of Adult Hodgkin LymphomaNational Cancer Institute
- Stages of Childhood Hodgkin LymphomaNational Cancer Institute
- Tests for Hodgkin LymphomaAmerican Cancer Society
Treatments and Therapies
- Bone Marrow Transplantation: MedlinePlus Health TopicNational Library of Medicine
- Drugs Approved for Hodgkin LymphomaNational Cancer Institute
- Integrative Medicine and Complementary TherapiesBlood Cancer United
- Treating Nodular Lymphocyte-Predominant Hodgkin LymphomaAmerican Cancer Society
- Treatment of Primary Refractory or Recurrent Hodgkin Lymphoma in Children and AdolescentsNational Cancer Institute
- Treatment Option Overview (Adult Hodgkin Lymphoma)National Cancer Institute
Prevention and Risk Factors
- Hodgkin Lymphoma Causes, Risk Factors, and PreventionAmerican Cancer Society
Living With
- After Hodgkin Lymphoma TreatmentAmerican Cancer Society
Related Issues
- General Information about AIDS-Related LymphomaNational Cancer Institute
- Hodgkin's vs. Non-Hodgkin's Lymphoma: What's the Difference?Mayo Foundation for Medical Education and Research
Statistics and Research
- Advances in Lymphoma ResearchNational Cancer Institute
- Hodgkin LymphomaNational Cancer Institute
- Key Statistics for Hodgkin LymphomaAmerican Cancer Society
Clinical Trials
- ClinicalTrials.gov: Hodgkin DiseaseNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Hodgkin Disease. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Hodgkin Lymphoma, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.